$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
西妥昔单抗是化疗药吗?西妥昔单抗怎么购买?
2025-10-19 11:44:20
Check Details
FOLFIRINOX新辅助治疗方案可改善晚期直肠癌的疾病控制
2025-10-19 11:44:20
Check Details
含糖饮料可能使50岁以下女性患肠癌的风险增加一倍
2025-10-19 11:44:20
Check Details
2021年瑞格非尼进医保了吗?瑞格非尼报销后自己花多少钱?
2025-10-19 11:44:20
Check Details
靶向药雷莫芦单抗2021年多少钱一支?雷莫芦单抗纳入国家医保了吗?
2025-10-19 11:44:20
Check Details
雷莫芦单抗能作为转移性结直肠癌的二线疗法吗?
2025-10-19 11:44:20
Check Details
【最多阅览】雷莫芦单抗是安维汀治疗转移性结直肠癌失败后的选择吗?
2025-10-19 11:44:20
Check Details
新药曲氟尿苷替匹嘧啶片属于医保可报销药品吗?
2025-10-19 11:44:20
Check Details
曲氟尿苷替匹嘧啶片进入医保了吗?医保给报销吗?
2025-10-19 11:44:20
Check Details
曲氟尿苷替匹嘧啶片用于转移性结直肠癌的有效性及安全性
2025-10-19 11:44:20
Check Details
结直肠癌新药:曲氟尿苷替匹嘧啶片(朗斯福)国内获批上市了吗?
2025-10-19 11:44:20
Check Details
【患者关心】西妥昔单抗在2021年医保报销后的价格
2025-10-19 11:44:20
Check Details
1
2
...
1628
1629
1630
1631
1632
1633
1634
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pemigatinib for FGFR2 Cholangiocarcinoma and FGFR1 Hematologic Use: First-Line Data, 21-Day Dosing, Phosphate and Ocular Management
2
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
3
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
4
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
5
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
6
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
7
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
8
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
9
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
10
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
11
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
12
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity